ACE and heart failure: Traditional pharmacotherapy for heart failure with reduced ejection fraction includes blockers of angiotensin-converting enzyme, beta-adrenoceptors and mineralocorticoid receptors which typically improve ejection fraction by 5–7% and life longevity [21, 44].